🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1, multi-center, open-label, drug-drug interaction (DDI) an...
Status
Completed
Location
Research Site
Start Date
2013-09
Trial ID
NCT01937260
Treatments Being Tested
This is an extension study for subjects who participated in Protocol 200900...
Status
Terminated
Location
Research Site
Start Date
2010-06-03
Trial ID
NCT01059448
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of brodaluma...
Status
Terminated
Location
Research Site
Start Date
2012-08
Trial ID
NCT01708590
Treatments Being Tested
This Phase 1b/2a study will evaluate safety, tolerability pharmacokinetics ...
Status
Completed
Location
Multiple Locations
Start Date
2008-10-27
Trial ID
NCT00771030
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of brodaluma...
Status
Terminated
Location
Research Site
Start Date
2012-08
Trial ID
NCT01708603
Treatments Being Tested
The study evaluated the efficacy of AMG 827 compared with placebo as measur...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT00975637
The primary objective of this study is to evaluate the efficacy of brodalum...
Status
Terminated
Location
Research Site
Start Date
2014-03
Trial ID
NCT02029495
Treatments Being Tested
This Phase 1 study will evaluate safety, tolerability, PK and PD of AMG 827...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00867100
The purpose of this study is to determine if brodalumab (AMG 827) is safe a...
Status
Terminated
Location
Research Site
Start Date
2013-05-22
Trial ID
NCT01902290
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of brodalum...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02024646
Treatments Being Tested